Biomarkers

TECHNOLOGY: Plasma markers

Detection of a panel of circulating tumor cell (CTC)-derived RNA transcripts in blood could help predict survival and disease progression in metastatic melanoma patients receiving immune checkpoint

Read the full 296 word article

User Sign In